DOJ Denies 'Rewriting' Price-Fix Indictment of Glenmark, Teva
The U.S. Department of Justice has derided claims by Glenmark and Teva that the antitrust enforcer is trying to assert a much broader price-fixing conspiracy involving more drugs than were included...To view the full article, register now.
Already a subscriber? Click here to view full article